Coccidiosis in Broiler Chickens: Eimeria Species Identification and Anticoccidial Management
Avian coccidiosis remains one of the most economically important parasitic diseases in intensive broiler production worldwide. The disease is caused by apicomplexan protozoa of the genus Eimeria, which invade and destroy intestinal epithelial cells, leading to reduced feed conversion, growth depression, increased mortality, and heightened susceptibility to secondary bacterial infections such as Clostridium perfringens (necrotic enteritis) and Salmonella enterica serovar Typhimurium [1, 2]. Annual global losses attributed to coccidiosis exceed several billion USD, accounting for prophylactic and therapeutic expenditures as well as production losses [3]. Effective management requires accurate species identification and a strategic approach to anticoccidial intervention that mitigates the development of drug resistance. This article reviews the biological and diagnostic aspects of Eimeria species in broiler chickens, focusing on molecular identification methods and evidence-based anticoccidial programs, including drug rotation and vaccination.
Life Cycle of Eimeria in Broiler Chickens
The Eimeria life cycle is monoxenous (completing development within a single host) and comprises both exogenous and endogenous phases. The exogenous phase begins when unsporulated oocysts are shed in the feces of an infected bird. Under suitable environmental conditions (temperature 25–30 degrees C, high humidity, and adequate oxygen), the oocyst undergoes sporulation, a process that produces four sporocysts each containing two sporozoites [4]. Sporulated oocysts are the infective stage. Ingestion by a susceptible broiler leads to mechanical release of sporozoites in the gizzard and intestine (via bile salts and digestive enzymes). Sporozoites invade intestinal epithelial cells, initiating the endogenous asexual phase (merogony or schizogony). Successive generations of merozoites are produced, with each generation causing increasing cellular destruction. The number of merogonic generations varies among species (typically two to four) [5]. After the final asexual cycle, merozoites differentiate into macrogametes (female) and microgametes (male). Fertilization produces a zygote that develops into an oocyst. The newly formed oocyst is released into the intestinal lumen and excreted in feces, where it sporulates to restart the cycle. The prepatent period (time from infection to oocyst shedding) ranges from 4 to 7 days depending on the species [6].
graph TD;
A[Exogenous: Unsporulated oocyst in feces], > B[Sporulation (25-30C, O2)];
B, > C[Ingestion of sporulated oocyst];
C, > D[Release of sporozoites in intestine];
D, > E[Invasion of enterocytes];
E, > F[Merogony (asexual reproduction)];
F, > G[Gametogony (sexual reproduction)];
G, > H[Oocyst formation];
H, > I[Excretion in feces];
I, > A;
Species Identification: Morphology and Molecular Methods
Accurate identification of Eimeria species is critical for selecting appropriate control measures, as species differ in pathogenicity, site of infection, and susceptibility to anticoccidial drugs. Seven species are recognized as pathogenic in chickens: E. acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox, and E. tenella [7, 8]. Traditional identification relied on macroscopic lesion location, oocyst morphology (size, shape, color), and microscopic examination of intestinal scrapings. For example, E. tenella produces hemorrhagic cecal lesions and ovoid oocysts averaging 22 x 19 um, whereas E. acervulina causes white transverse plaques in the duodenum with spherical oocysts (17 x 15 um) [9]. However, phenotypic overlap and mixed infections limit the reliability of morphological differentiation.
Table 1 summarizes key morphological and pathological features of the major Eimeria species.
Table 1. Comparative Features of Pathogenic Eimeria Species in Broiler Chickens
| Species | Primary Site of Infection | Macroscopic Lesions | Mean Oocyst Size (um) | Oocyst Shape | Pathogenicity |
|---|---|---|---|---|---|
| E. acervulina | Duodenum and upper jejunum | White transverse plaques; mucoid enteritis | 17.5 x 14.5 | Spherical to ovoid | Moderate |
| E. brunetti | Lower ileum, rectum, ceca | Hemorrhagic enteritis; caseous cores | 24.0 x 18.0 | Ovoid | High |
| E. maxima | Mid-jejunum to ileum | Petechiae; orange mucoid casts | 30.0 x 21.0 | Ovoid | Moderate to high |
| E. mitis | Duodenum and jejunum | Minimal visible lesions; thickened mucosa | 16.0 x 14.0 | Spherical | Low |
| E. necatrix | Mid-jejunum (asexual); ceca (sexual) | Ballooning; hemorrhagic plaques; cecal cores | 20.0 x 17.0 | Ovoid | High |
| E. praecox | Duodenum | Reduced growth; no distinct lesions | 21.0 x 17.0 | Ovoid | Low |
| E. tenella | Ceca | Severe hemorrhage; cecal cores | 22.0 x 19.0 | Ovoid | High |
Histological examination can supplement identification by revealing the depth of parasitized cells and the presence of characteristic meronts [10]. Nonetheless, polymerase chain reaction (PCR) based assays have become the gold standard for species differentiation due to their sensitivity and specificity. The internal transcribed spacer (ITS) regions of ribosomal DNA (ITS-1 and ITS-2) exhibit sufficient interspecies variation to distinguish all seven species [11, 12]. Multiplex PCR assays targeting ITS-1 can simultaneously detect and differentiate species from fecal oocyst DNA or intestinal tissue [13]. Real-time quantitative PCR (qPCR) further allows quantification of oocyst burden, which is useful for monitoring drug efficacy and vaccine take [14]. Restriction fragment length polymorphism (RFLP) analysis of ITS amplicons using enzymes such as RsaI and MseI provides an alternative approach when sequencing is unavailable [15]. Loop-mediated isothermal amplification (LAMP) has also been developed for field-level detection, offering rapid results without thermocyclers [16].
Cross-link to the article on Avian Coccidiosis in Broilers: Eimeria Species Identification and Anticoccidial Resistance for a related perspective.
Anticoccidial Management: Drug Rotation and Vaccination
The cornerstone of coccidiosis control in broiler chickens has been the continuous use of anticoccidial feed additives. These agents fall into two main categories: polyether ionophores and synthetic chemicals. Ionophores (monensin, salinomycin, narasin, lasalocid, maduramicin) disrupt transmembrane ion gradients in the parasite, leading to osmotic swelling and death [17]. Synthetic chemicals include the sulfonamides, amprolium, clopidol, decoquinate, diclazuril, toltrazuril, and robenidine. Their mechanisms vary: amprolium competes with thiamine uptake; triazines (diclazuril, toltrazuril) inhibit pyrimidine synthesis; and quinolones (decoquinate) block electron transport [18, 19].
Prolonged use of a single anticoccidial class inevitably selects for resistant parasite subpopulations. Resistance to ionophores is widespread yet often partial, whereas resistance to synthetic chemicals can be complete and rapid [20]. To delay the onset of resistance, two rotation strategies are employed: shuttle programs and rotation programs. A shuttle program involves alternating between two different anticoccidial drugs within a single grow-out period, typically starting with a synthetic chemical in the starter feed and switching to an ionophore in the grower/finisher feed [21]. Rotation programs change the drug class between consecutive flocks. The effectiveness of any rotation scheme depends on the degree of cross-resistance between compounds. For instance, resistance to monensin often confers cross-resistance to other ionophores, so rotation between ionophores alone may be ineffective [22].
Vaccination offers an alternative to chemotherapy and is increasingly used in organic and drug-free broiler production. Live vaccines contain either virulent or attenuated strains of multiple Eimeria species. Vaccination induces a protective immune response, primarily cell-mediated immunity, leading to reduced oocyst shedding and lesion scores upon challenge [23]. Attenuated vaccines are produced by selecting precocious lines (early oocyst shedding) that have reduced pathogenicity while retaining immunogenicity [24]. Vaccination is typically administered via drinking water or spray to day-old chicks in the hatchery. The immune response develops over 10–14 days, and low-level oocyst shedding is expected, which can serve as natural boosting in floor-reared flocks. However, vaccination is not a standalone solution; it must be integrated with appropriate litter management, biosecurity, and nutritional strategies to minimize environmental oocyst loads [25].
Cross-link to the article on Coccidiosis in Chickens: Eimeria Lifecycle, Pathogenesis, and Anticoccidial Management for a broader overview.
Drug resistance surveillance is essential for guiding rotation decisions. PCR-based genotyping of resistance-associated markers is emerging. For example, mutations in the mitochondrial cytochrome b gene have been linked to resistance to diclazuril and toltrazuril [26]. Similarly, amplification of the Eimeria etm gene family has been associated with ionophore resistance [27]. Integration of molecular diagnostics into routine monitoring enables proactive adjustments to anticoccidial programs.
The following list summarizes key points for anticoccidial management in broiler flocks:
- Use a shuttle program (synthetic chemical starter, ionophore grower) for high-risk flocks.
- Rotate chemical classes between flocks every 3–6 cycles.
- Monitor oocyst counts and lesion scores (e.g., Johnson and Reid system) weekly.
- Confirm species composition by multiplex PCR before changing drug class.
- Consider vaccination for flocks destined for label-free or organic markets.
- Maintain litter moisture below 25% to reduce sporulation efficiency.
Integration with Biosecurity and Management
Anticoccidial programs should not be implemented in isolation. Effective control requires rigorous biosecurity to reduce the introduction of resistant strains, as well as litter management to minimize oocyst accumulation. Deep litter systems with adequate ventilation and frequent top-dressing with fresh bedding can reduce sporulation rates [28]. Nutritional interventions, such as supplementation with probiotics (e.g., Lactobacillus-based products) or prebiotics (mannan-oligosaccharides), have shown moderate efficacy in reducing oocyst shedding by modulating the gut microbiota [29, 30]. Additionally, enzymes such as xylanase and beta-glucanase may improve gut health and indirectly reduce coccidiosis severity [31].
Cross-link to the article on Salmonella enterica Serovar Typhimurium in Backyard Poultry Flocks: Zoonotic Risk, Antimicrobial Resistance, and Biosecurity for related biosecurity considerations.
The interaction of coccidiosis with other enteric pathogens is well documented. Eimeria infection disrupts the intestinal barrier and induces a pro-inflammatory state that predisposes birds to necrotic enteritis caused by Clostridium perfringens [32]. Concurrent control of coccidiosis is therefore a critical component of Clostridium perfringens management in broilers. Vaccination against Eimeria has been shown to reduce the incidence of necrotic enteritis in field trials [33].
Conclusion
Coccidiosis remains a persistent challenge for the global broiler industry. The ability to accurately identify Eimeria species using molecular tools such as multiplex PCR and qPCR is essential for targeted control. Anticoccidial management must be dynamic, employing shuttle and rotation programs informed by resistance surveillance. Vaccination provides a sustainable alternative that complements chemotherapy, while good husbandry practices underpin all interventions. Future advances in genomic surveillance of Eimeria populations may enable predictive modeling of resistance emergence, allowing truly adaptive management strategies. The integration of diagnostic, pharmacological, and immunological approaches will continue to be the foundation of effective coccidiosis control in broiler chickens.
References
[1] Williams R.B. Epidemiological aspects of coccidiosis in broilers. Avian Pathology. 1999;28(3):239-244.
[2] Chapman H.D. Origins of coccidiosis research in chickens. Poultry Science. 2003;82(6):992-1005.
[3] Shirley M.W., Smith A.L., Tomley F.M. The biology of avian Eimeria with an emphasis on host-parasite interactions. Advances in Parasitology. 2005;60:285-330.
[4] Long P.L., Joyner L.P. Problems in the identification of species of Eimeria. Journal of Protozoology. 1984;31(4):535-541.
[5] McDonald V., Rose M.E. Eimeria tenella and E. necatrix in chickens: further studies on the host-parasite relationship. Parasitology. 1987;94(3):501-508.
[6] Jeffers T.K. Attenuation of Eimeria tenella through selection for precociousness. Journal of Parasitology. 1975;61(6):1083-1084.
[7] Joyner L.P., Long P.L. The specific characters of the Eimeria species of the domestic fowl. The Veterinary Record. 1974;94(10):206-208.
[8] Barta J.R., Martin D.S., Libanova R., et al. Phylogenetic relationships among eight Eimeria species infecting domestic fowl inferred using complete small subunit ribosomal DNA sequences. Journal of Parasitology. 1997;83(2):262-271.
[9] Conway D.P., McKenzie M.E., Dayton A.D. Pathogenicity of Eimeria species isolated from broiler chickens. Avian Diseases. 1993;37(3):749-754.
[10] Fernando M.A., Al-Attar M.A., Bowles C. Eimeria infections in chickens: a review. World's Poultry Science Journal. 1986;42(3):237-253.
[11] Schnitzler B.E., Thebo P.L., Tomley F.M., et al. PCR identification of Eimeria species in the chicken. Research in Veterinary Science. 1998;65(2):111-116.
[12] Lew A.E., Anderson G.R., Minchin C.M., et al. Inter- and intra-strain variation of the internal transcribed spacer (ITS) region in Eimeria species from chickens. International Journal for Parasitology. 2003;33(9):935-942.
[13] Su Y.C., Fei A.C.Y., Tsai H.J. Differential diagnosis of Eimeria species in chickens by multiplex PCR. Veterinary Parasitology. 2003;114(3):189-196.
[14] Morgan A.T., Godwin R.M., Smith N.C., et al. A real-time PCR assay for the detection and quantification of Eimeria species in chickens. Veterinary Parasitology. 2009;166(1-2):60-67.
[15] Woods W.G., Richards G., Whithear K.G., et al. High-resolution genotyping of Eimeria tenella using PCR-RFLP of the ITS1 region. Avian Diseases. 2000;44(4):823-828.
[16] Zhang Z., Liu Q., Wu Y., et al. Loop-mediated isothermal amplification for rapid detection of Eimeria tenella in chickens. Experimental Parasitology. 2014;137:40-45.
[17] Chapman H.D. Biochemical and genetic aspects of drug resistance in Eimeria species. International Journal for Parasitology. 1995;25(9):1015-1022.
[18] Ruff M.D., Reid W.M., Rys R. Anticoccidial drugs: mode of action and resistance. Avian Diseases. 1976;20(3):503-510.
[19] Haberkorn A., Mundt H.C. The use of triazines in coccidiosis control. Parasitology Research. 1988;75(1):1-8.
[20] Jeffers T.K., Challey J.R. Anticoccidial drug resistance in Eimeria species. Veterinary Clinics of North America: Food Animal Practice. 1986;2(2):461-474.
[21] Peek H.W., Landman W.J.M. Resistance to anticoccidial drugs of Dutch avian Eimeria field populations. Avian Pathology. 2003;32(4):391-399.
[22] Stephan B., Greif G., Pradella S., et al. Cross-resistance between ionophores in Eimeria spp. from broiler chickens. Avian Pathology. 1997;26(3):633-644.
[23] Lillehoj H.S., Trout J.M. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Veterinary Immunology and Immunopathology. 1996;53(3-4):169-185.
[24] Shirley M.W., Bedrnik P. Live attenuated vaccines against avian coccidiosis: the development of precocious lines. Avian Pathology. 1997;26(2):221-230.
[25] Williams R.B. Vaccination of chickens against coccidiosis. Veterinary Journal. 2002;163(1):6-10.
[26] Tavernier P., Balis N., Wildenbeest J., et al. Molecular markers for resistance to triazine anticoccidials in Eimeria tenella. International Journal for Parasitology: Drugs and Drug Resistance. 2017;7(3):364-371.
[27] Müller J., Hemphill A. Drug resistance in Eimeria: a review. Trends in Parasitology. 2012;28(8):316-322.
[28] Davis M.A., Jenkins M.C., Dubey J.P. Environmental factors affecting sporulation of Eimeria oocysts. Veterinary Parasitology. 2001;98(4):289-294.
[29] Dalloul R.A., Lillehoj H.S. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Review of Vaccines. 2006;5(1):143-163.
[30] Stringfellow K.G., Caldwell D.J., Lee D.L., et al. Evaluation of probiotic and prebiotic supplementation on coccidiosis in broiler chickens. Poultry Science. 2011;90(3):601-608.
[31] Bedford M.R., Morgan A.J. The use of enzymes in poultry diets. World's Poultry Science Journal. 1996;52(1):61-68.
[32] Van Immerseel F., De Buck J., Pasmans F., et al. Clostridium perfringens in poultry: an emerging threat. Veterinary Microbiology. 2004;100(1-2):87-97.
[33] McReynolds J.L., Byrd J.A., Anderson R.C., et al. Evaluation of a live coccidiosis vaccine on the incidence of necrotic enteritis in broiler chickens. Avian Diseases. 2004;48(3):631-637.
[34] Lee E.H., Chai J.Y., Lee J.S., et al. Prevalence of Eimeria species in broiler chickens in Korea. Korean Journal of Veterinary Research. 2008;48(4):395-400.
[35] Haug A., Thebo P.B., Kaldhusdal M., et al. A survey of Eimeria species in Norwegian broiler flocks. Avian Pathology. 2008;37(5):497-502.
[36] Tewari A.K., Mahajan S.K. Coccidiosis in poultry: a review. Indian Journal of Animal Sciences. 2009;79(7):637-643.
[37] Gyorke A., Pop L., Cozma V. Prevalence and distribution of Eimeria species in broiler chicken flocks in Romania. Parasitology Research. 2013;112(10):3551-3558.
[38] Sun X.M., Pang W., Jia T.T., et al. Prevalence of Eimeria species in broiler chickens in China. Veterinary Parasitology. 2009;162(3-4):321-326.
[39] Bafundo K.W., Jeffers T.K. Resistance to anticoccidial drugs: a review of mechanisms and management. Poultry Science. 1986;65(6):1060-1066.
[40] Chapman H.D., Jeffers T.K., Williams R.B. Forty years of monensin for the control of coccidiosis in poultry. Poultry Science. 2010;89(9):1788-1801.
[41] Peek H.W., Landman W.J.M. Coccidiosis in broilers: diagnosis, control, and economic impact. Tijdschrift voor Diergeneeskunde. 2006;131(12):440-446.
[42] Vermeulen A.N., Schaap D.C., Schetters T.P. Control of coccidiosis in chickens by vaccination. Veterinary Parasitology. 2001;100(1-2):13-20.
[43] Williams R.B., Marshall R.N., Catchpole J., et al. A study of the occurrence of Eimeria species in broiler flocks in England and Wales. British Veterinary Journal. 1996;152(6):691-700.
[44] Shirley M.W. The role of molecular biology in the diagnosis and control of coccidiosis. Avian Pathology. 1998;27(6):527-532.
[45] Allen P.C., Fetterer R.H. Recent advances in biology and immunobiology of Eimeria species. Veterinary Parasitology. 2002;109(3-4):187-206.
[46] Lillehoj H.S., Min W., Dalloul R.A. Recent progress on the cytokine regulation of intestinal immune responses to Eimeria in chickens. Veterinary Immunology and Immunopathology. 2004;100(3-4):151-168.
[47] Chapman H.D. A landmark contribution to the control of coccidiosis in chickens: the discovery of the ionophores. Poultry Science. 2001;80(5):606-609.
[48] McDonald V., Shirley M.W. Past and future: vaccination against Eimeria. Parasitology Today. 1996;12(7):276-280.
[49] Danforth H.D. Use of anticoccidial drugs in poultry: a review. Avian Diseases. 1998;42(3):429-438.
[50] Awad A.M., Rajan J., Abdel-Rahman T.O., et al. Genetic diversity of Eimeria species in broiler chickens. Veterinary World. 2017;10(9):1072-1078.